Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Janssen-cilag G.m.b.h

Clinical trials sponsored by Janssen-cilag G.m.b.h, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

German subsidiary of Johnson & Johnson's pharmaceutical division, developing and marketing medicines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Real-world study tracks guselkumab's impact on IBD patients

Disease control Recruiting now

This study will follow 500 people with Crohn's disease or ulcerative colitis who are starting guselkumab, a biologic drug. Researchers will measure how many achieve remission and how the treatment affects daily life, including fatigue and work productivity. The goal is to underst…

Sponsor: Janssen-Cilag G.m.b.H • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC